Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway

BACKGROUND: Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated. METHODS: Here, network pharmacology and molecular docking...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feifei, Shi, Youyang, Zhang, Yang, Yang, Xiaojuan, Wang, Yi, Jiang, Kexin, Hua, Ciyi, Wu, Chunyu, Sun, Chenping, Qin, Yuenong, Liu, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981688/
https://www.ncbi.nlm.nih.gov/pubmed/35379271
http://dx.doi.org/10.1186/s13020-022-00597-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981688/
https://www.ncbi.nlm.nih.gov/pubmed/35379271
http://dx.doi.org/10.1186/s13020-022-00597-5

Ejemplares similares